IAXO-102
Product Specifications
UNSPSC Description
IAXO-102 is a TLR4 antagonist which negatively regulates TLR4 signalling. IAXO-102 inhibits MAPK and p65 NF-κB phosphorylation and expression of TLR4 dependent proinflammatory protein. IAXO-102 also prevents experimental abdominal aortic aneurysm development[1].
Target Antigen
Toll-like Receptor (TLR)
Type
Reference compound
Related Pathways
Immunology/Inflammation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/IAXO-102.html
Purity
98.0
Solubility
DMSO : 3.33 mg/mL (ultrasonic;warming;heat to 60°C)|Ethanol : 50 mg/mL (ultrasonic)
Smiles
CCCCCCCCCCCCCCO[C@@H]1[C@H]([C@@H]([C@@H](CN)O[C@@H]1OC)O)OCCCCCCCCCCCCCC
Molecular Weight
585.94
References & Citations
[1]Huggins C, et al. A novel small molecule TLR4 antagonist (IAXO-102) negatively regulates non-hematopoietic toll like receptor 4 signalling and inhibits aortic aneurysms development. Atherosclerosis. 2015 Oct;242(2):563-70.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-125171/IAXO-102-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-125171/IAXO-102-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1115270-63-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![SAPK4 (MAPK13) Mouse Monoclonal Antibody [Clone ID: LBI2D1]](https://cdn.genprice.uk/genprice/genprice2.png)
